| Literature DB >> 32607295 |
Mohammed Alghamdi1, Tiffani Mathew2, Andrea Breaux2, Harpreet Chopra2.
Abstract
Heterotopic bone formation is a rare phenomenon when associated with gastrointestinal neoplasms. Here we present a rare case of heterotopic ossification associated with goblet cell adenocarcinoma of the appendix, and a literature review of such cases associated with neoplasms within and out of the gastrointestinal tracts. We reviewed the clinical data and when available, immunohistochemical markers of osteoblastic differentiation. Our review shows similar findings to prior reports of apparent high association of heterotopic bone formation with neoplasms with mucinous features. Two, previously proposed main hypotheses of the mechanisms are reviewed. The unique feature about this case is that goblet cell adenocarcinoma was not reported previously in the setting of bone formation.Entities:
Keywords: goblet cell adenocarcinoma; heterotopic bone; ossification
Year: 2020 PMID: 32607295 PMCID: PMC7320657 DOI: 10.7759/cureus.8312
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1CT scan for abdomen and pelvis with contrast shows a large pelvic mass measuring 9.7 cm x 8.8 cm on the cross-sectional image (left), the coronal section showing lesional punctate hyperdensities compatible with ossification (right).
Figure 2Gross photograph of the appendiceal tumor showing the obliterated lumen with calcification at the center (arrow).
Figure 3Photomicrographs of the appendiceal tumor. (A) Predominantly tubular proliferation of tumor cells with surrounding desmoplastic reaction. (B) Glandular elements and single cells invading the mesoappendix. (C, D) Formation of bone lined by osteoblasts. (E, F) Show tumor cells positive for synaptophysin and CD56, respectively. (Hematoxylin and Eosin stains and immunohistochemical studies, 20x)
Summary of reported cases of neoplasia with heterotopic ossification and immunohistochemical studies performed.
Gli2: glioma-associated oncogene family zinc finger 2, a-SMA: smooth muscle actin, BMP-2: bone morphogenetic protein 2, BMP-9: bone morphogenetic protein 9, bFGF: basic fibroblast growth factor, VEGF: vascular endothelial growth factor, TGF- β1: transforming growth factor, Runx2: Runt-related transcription factor 2.
| Organ | Author | Tumor type | IHC markers tested |
| Colon | Huang et al. (2014) [ | Adenocarcinoma | Osteonectin, Gli2, Nestin, a-SMA |
| Lung | Suzuki et al. (2019) [ | Adenocarcinoma | BMP-2, Osteopontin |
| Rectum | Kypson et al. (2003) [ | Adenocarcinoma | Osteocalcin, Osteopontin, β-catenin, BMP9 |
| Thyroid | Takeda et al. (2013) [ | Papillary thyroid carcinoma | bFGF, BMP-2, VEGF |
| Lung | Kim et al. (2009) [ | Adenocarcinoma | TGF-β1, Osteopontin, Osteocalcin, Runx2 |
| Lung | Tsubochi et al. (2013) [ | Carcinoid tumor | BMP-2, Osteocalcin |
| Rectum | Smajda et al. (2015) [ | Adenocarcinoma | Not performed |
Reported cases of neoplasia from the appendix with heterotopic ossification.
BMP9: bone morphogenetic protein 9, ALK1: anaplastic lymphoma kinase 1
| Case | Age (sex) | Past medical history | Diagnosis | Size (cm) | IHC |
| Juvara et al. (1948) [ | 70 (M) | Strangulation of a right inguinoscrotal hernia | Perforated mucocele | 7.0 | NA |
| Haque et al. (1996) [ | 46 (F) | Chronic ulcerative colitis, in remission | Mucinous cystadenocarcinoma | 2.0 | NA |
| Choi et al. (2016) [ | 44(F) | Papillary thyroid carcinoma | Mucinous cystadenoma | 3.5 | NA |
| Choi et al. (2016) [ | 56 (F) | Abdominal pain | Low-grade appendiceal mucinous neoplasm | 7.0 | NA |
| Choi et al. (2016) [ | 58 (F) | Incidental pelvic mass | Mucinous cystadenocarcinoma | 8.0 | NA |
| Noh et al. (2016) [ | 72 (F) | Dyspepsia, weight loss, hyperlipidemia | Perforated low-grade appendiceal mucinous neoplasm | 8.0 | BMP9, ALK1, Osteocalcin, Osteopontin |
| Current case | 57 (M) | Abdominal pain | Adenocarcinoma ex goblet cell carcinoid | 5.0 | NA |